543 related articles for article (PubMed ID: 27987324)
1. TUDCA: An Agonist of the Bile Acid Receptor GPBAR1/TGR5 With Anti-Inflammatory Effects in Microglial Cells.
Yanguas-Casás N; Barreda-Manso MA; Nieto-Sampedro M; Romero-Ramírez L
J Cell Physiol; 2017 Aug; 232(8):2231-2245. PubMed ID: 27987324
[TBL] [Abstract][Full Text] [Related]
2. Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation.
Yanguas-Casás N; Barreda-Manso MA; Nieto-Sampedro M; Romero-Ramírez L
J Neuroinflammation; 2014 Mar; 11():50. PubMed ID: 24645669
[TBL] [Abstract][Full Text] [Related]
3. The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP/PKA pathway in pancreatic beta cells.
Vettorazzi JF; Ribeiro RA; Borck PC; Branco RC; Soriano S; Merino B; Boschero AC; Nadal A; Quesada I; Carneiro EM
Metabolism; 2016 Mar; 65(3):54-63. PubMed ID: 26892516
[TBL] [Abstract][Full Text] [Related]
4. TGR5 Activation Promotes Stimulus-Secretion Coupling of Pancreatic β-Cells via a PKA-Dependent Pathway.
Maczewsky J; Kaiser J; Gresch A; Gerst F; Düfer M; Krippeit-Drews P; Drews G
Diabetes; 2019 Feb; 68(2):324-336. PubMed ID: 30409782
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy.
Mendes MO; Rosa AI; Carvalho AN; Nunes MJ; Dionísio P; Rodrigues E; Costa D; Duarte-Silva S; Maciel P; Rodrigues CMP; Gama MJ; Castro-Caldas M
Mol Cell Neurosci; 2019 Apr; 96():1-9. PubMed ID: 30771505
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of tauroursodeoxycholic acid on lipopolysaccharide-induced cognitive impairment and neurotoxicity in mice.
Wu X; Liu C; Chen L; Du YF; Hu M; Reed MN; Long Y; Suppiramaniam V; Hong H; Tang SS
Int Immunopharmacol; 2019 Jul; 72():166-175. PubMed ID: 30986644
[TBL] [Abstract][Full Text] [Related]
7. Effects of tauroursodeoxycholic acid on glucose homeostasis: Potential binding of this bile acid with the insulin receptor.
da Silva JA; Figueiredo LS; Chaves JO; Oliveira KM; Carneiro EM; Abreu PA; Ribeiro RA
Life Sci; 2021 Nov; 285():120020. PubMed ID: 34624320
[TBL] [Abstract][Full Text] [Related]
8. Taurochenodeoxycholic acid mediates cAMP-PKA-CREB signaling pathway.
Qi YC; Duan GZ; Mao W; Liu Q; Zhang YL; Li PF
Chin J Nat Med; 2020 Dec; 18(12):898-906. PubMed ID: 33357720
[TBL] [Abstract][Full Text] [Related]
9. G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype.
Högenauer K; Arista L; Schmiedeberg N; Werner G; Jaksche H; Bouhelal R; Nguyen DG; Bhat BG; Raad L; Rauld C; Carballido JM
J Med Chem; 2014 Dec; 57(24):10343-54. PubMed ID: 25411721
[TBL] [Abstract][Full Text] [Related]
10. INT-777 prevents cognitive impairment by activating Takeda G protein-coupled receptor 5 (TGR5) and attenuating neuroinflammation via cAMP/ PKA/ CREB signaling axis in a rat model of sepsis.
Jin P; Deng S; Tian M; Lenahan C; Wei P; Wang Y; Tan J; Wen H; Zhao F; Gao Y; Gong Y
Exp Neurol; 2021 Jan; 335():113504. PubMed ID: 33058889
[TBL] [Abstract][Full Text] [Related]
11. 3,3'-Diindolylmethane inhibits lipopolysaccharide-induced microglial hyperactivation and attenuates brain inflammation.
Kim HW; Kim J; Kim J; Lee S; Choi BR; Han JS; Lee KW; Lee HJ
Toxicol Sci; 2014 Jan; 137(1):158-67. PubMed ID: 24162184
[TBL] [Abstract][Full Text] [Related]
12. A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivo.
Lewis ND; Patnaude LA; Pelletier J; Souza DJ; Lukas SM; King FJ; Hill JD; Stefanopoulos DE; Ryan K; Desai S; Skow D; Kauschke SG; Broermann A; Kuzmich D; Harcken C; Hickey ER; Modis LK
PLoS One; 2014; 9(6):e100883. PubMed ID: 24967665
[TBL] [Abstract][Full Text] [Related]
13. Agonists for G-protein-coupled receptor 84 (GPR84) alter cellular morphology and motility but do not induce pro-inflammatory responses in microglia.
Wei L; Tokizane K; Konishi H; Yu HR; Kiyama H
J Neuroinflammation; 2017 Oct; 14(1):198. PubMed ID: 28974234
[TBL] [Abstract][Full Text] [Related]
14. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.
Wimmer R; Hohenester S; Pusl T; Denk GU; Rust C; Beuers U
Gut; 2008 Oct; 57(10):1448-54. PubMed ID: 18583398
[TBL] [Abstract][Full Text] [Related]
15. Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation.
Bhargava P; Smith MD; Mische L; Harrington E; Fitzgerald KC; Martin K; Kim S; Reyes AA; Gonzalez-Cardona J; Volsko C; Tripathi A; Singh S; Varanasi K; Lord HN; Meyers K; Taylor M; Gharagozloo M; Sotirchos ES; Nourbakhsh B; Dutta R; Mowry EM; Waubant E; Calabresi PA
J Clin Invest; 2020 Jul; 130(7):3467-3482. PubMed ID: 32182223
[TBL] [Abstract][Full Text] [Related]
16. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice.
Wang YD; Chen WD; Yu D; Forman BM; Huang W
Hepatology; 2011 Oct; 54(4):1421-32. PubMed ID: 21735468
[TBL] [Abstract][Full Text] [Related]
17. TGFβ Contributes to the Anti-inflammatory Effects of Tauroursodeoxycholic Acid on an Animal Model of Acute Neuroinflammation.
Yanguas-Casás N; Barreda-Manso MA; Pérez-Rial S; Nieto-Sampedro M; Romero-Ramírez L
Mol Neurobiol; 2017 Nov; 54(9):6737-6749. PubMed ID: 27744574
[TBL] [Abstract][Full Text] [Related]
18. Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5.
Qi Y; Shi L; Duan G; Ma Y; Li P
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885648
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental GMH rat model.
Tao Y; Li L; Jiang B; Feng Z; Yang L; Tang J; Chen Q; Zhang J; Tan Q; Feng H; Chen Z; Zhu G
Brain Behav Immun; 2016 Nov; 58():118-129. PubMed ID: 27261088
[TBL] [Abstract][Full Text] [Related]
20. Application of Tauroursodeoxycholic Acid for Treatment of Neurological and Non-neurological Diseases: Is There a Potential for Treating Traumatic Brain Injury?
Gronbeck KR; Rodrigues CM; Mahmoudi J; Bershad EM; Ling G; Bachour SP; Divani AA
Neurocrit Care; 2016 Aug; 25(1):153-66. PubMed ID: 26759227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
